1-20 of 47
Maria Lia Palomba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma

Roni Shouval, Ana Alarcon Tomas, Joshua A Fein, Jessica Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Connie Lee Batlevi, Parastoo B. Dahi, Sean M Devlin, Warren Fingrut, Sergio A Giralt, Richard J Lin, Gilles Salles, Craig S. Sauter, Michael Scordo, Gunjan L Shah, Nishi Shah, Ruth Scherz Shouval, Marcel van den Brink, Miguel-Angel Perales, Maria Lia Palomba
Journal: Blood
Blood (2021) 138 (Supplement 1): 710.
DOI: https://doi.org/10.1182/blood-2021-145158
Published: 2021
Journal Articles

The Intestinal Microbiota Correlates with Response and Toxicity after CAR T Cell Therapy in Patients with B-Cell Malignancies

Melody Smith, Anqi Dai, Guido Ghilardi, Kimberly Amelsberg, Sean M Devlin, Raymone Pajarillo, John B Slingerland, Silvia Beghi, Pamela S Herrera, Paul A Giardina, Annelie Clurman, Emmanuel A Dwomoh, Gabriel K Armijo, Antonio L.C. Gomes, Eric R Littmann, Jonas Schluter, Emily Fontana, Ying Taur, Jae H Park, Maria Lia Palomba, Elizabeth Halton, Josel D Ruiz, Tania Jain, Martina Pennisi, Aishat Olaide Afuye, Miguel-Angel Perales, Craig W. Freyer, Alfred L Garfall, Shannon H Gier, Sunita Nasta, Daniel J Landsburg, James N Gerson, Jakub Svoboda, Justin Cross, Elise A Chong, Sergio A Giralt, Saar Gill, Isabelle Rivière, David L Porter, Stephen J Schuster, Michel Sadelain, Noelle V Frey, Renier J Brentjens, Carl H June, Eric G Pamer, Jonathan U Peled, Marco Ruella, Marcel van den Brink, Andrea Facciabene
Journal: Blood
Blood (2021) 138 (Supplement 1): 253.
DOI: https://doi.org/10.1182/blood-2021-153945
Published: 2021
Journal Articles

Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience

Lorenzo Falchi, Annie Qiu, Mark D. Ewalt, Connie Lee Batlevi, Philip C Caron, Paul A. Hamlin, Audrey Hamilton, Steven M. Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Ahmet Dogan, Klaus Busam, Patricia Myskowski, Joachim Yahalom, Gilles Salles, Matthew J. Matasar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2513.
DOI: https://doi.org/10.1182/blood-2021-151994
Published: 2021
Journal Articles

Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, MD, Gunjan Shah, MD, Heiko Schöder, MD, Nivetha Ganesan, MPH, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Samia Sohail, BA, Alayna Santarosa, Lauren Pomerantz, BS, Christine Jarjies, MS, Natasha Galasso, BA, Rachel Neuman, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MDPhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Lorenzo Falchi, MD, Erel Joffe, MD MSc, Maria Lia Palomba, Ariela Noy, MD, Matthew J Matasar, MD, Georgios Pongas, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
DOI: https://doi.org/10.1182/blood-2020-138434
Published: 2020
Journal Articles

Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data

Ibrahim Tohidi-Esfahani, MBBS,FRACP,FRCPA, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, Stephen Opat, MBBS (Hons), FRACP, FRCPA, Shirley D'Sa, MD FRCPath, Marie José Kersten, MD PhD, Ruth Spearing, MD, Maria Lia Palomba, Adam J Olszewski, MD, Carl Harrington, Clare Scott, MBBS PhDFRACP, Judith Trotman, FRACP
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
DOI: https://doi.org/10.1182/blood-2020-138945
Published: 2020
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
DOI: https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001

Maria Lia Palomba, MD, Leo I. Gordon, MD, Tanya Siddiqi, MD, Jeremy S. Abramson, MD, Manali Kamdar, MD, Matthew A. Lunning, DO, FACP, David G. Maloney, MD PhD, Charalambos Andreadis, MD MSCE, Jon E. Arnason, MD, Nilanjan Ghosh, MD PhD, Amitkumar Mehta, MD, Scott R. Solomon, MD, Thalia Farazi, MD PhD, Jacob Garcia, MD, Christine Dehner, BSc, Ken Ogasawara, PhD MPH, Jie Gao, PhD, Michael Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
DOI: https://doi.org/10.1182/blood-2020-136158
Published: 2020
Journal Articles

Favorable Outcomes Among Patients with T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with Higher-Intensity Therapy in the Rituximab Era

Edith Tama Robin, MD, Esther Drill, DrPH, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Lorenzo Falchi, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MD MSc, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD, Alison J. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
DOI: https://doi.org/10.1182/blood-2020-136489
Published: 2020
Journal Articles

Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Richard J Lin, MD PhD, Stephanie M Lobaugh, MS, Martina Pennisi, Jason T Chan, RN, Yakup Batlevi, PhD, Josel D Ruiz, MPH, Theresa A Elko, MS, Molly A. Maloy, MS, Connie Lee Batlevi, MD PhD, Parastoo B. Dahi, MD, Sergio A Giralt, MD, Elena Mead, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Bianca Santomasso, MD PhD, Craig S. Sauter, MD, Michael Scordo, MD, Gunjan L. Shah, MD, Beatriz Korc-Grodzicki, MD PhD, Soo Jung Kim, NP, Mari Lynne Silverberg, Chelsea A Brooklyn, Sean M. Devlin, PhD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1603.
DOI: https://doi.org/10.1182/blood-2019-125162
Published: 2019
Journal Articles

Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells

Martina Pennisi, Miriam Sanchez-Escamilla, MD, Jessica Flynn, BS, Molly A. Maloy, MS, Mari Lynne Silverberg, Yakup Batlevi, PhD, Roni Shouval, Connie Lee Batlevi, MD PhD, Renier J. Brentjens, MD PhD, Sean M. Devlin, PhD, Parastoo B. Dahi, MD, Claudia Diamonte, RN, Sergio A Giralt, MD, Elizabeth Halton, NP-BC AOCNP, Tania Jain, MD, Elena Mead, MD, Maria Lia Palomba, MD, Bianca Santomasso, MD PhD, Craig S. Sauter, MD, Michael Scordo, MD, Gunjan L. Shah, MD, Jae H. Park, MD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1947.
DOI: https://doi.org/10.1182/blood-2019-126208
Published: 2019
Journal Articles

Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas

Jeremy S. Abramson, MD MMSc, Maria Lia Palomba, MD, Leo I. Gordon, MD, Matthew A. Lunning, DO, FACP, Michael L. Wang, MD, Jon E. Arnason, MD, Amitkumar Mehta, MD, Enkhtsetseg Purev, MD PhD, David G. Maloney, MD PhD, Charalambos Andreadis, MD MSCE, Alison R. Sehgal, MD, Scott R. Solomon, MD, Nilanjan Ghosh, MD PhD, Tina Albertson, MD, Jacob Garcia, MD, Ana Kostic, Daniel Li, PhD, Yeonhee Kim, Tanya Siddiqi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 241.
DOI: https://doi.org/10.1182/blood-2019-127508
Published: 2019
Journal Articles

Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management

Martina Pennisi, Tania Jain, MD, Elena Mead, MD, Bianca Santomasso, MD PhD, Mari Lynne Silverberg, Yakup Batlevi, PhD, Roni Shouval, Molly A. Maloy, MS, Sean M. Devlin, PhD, Connie Lee Batlevi, MD PhD, Renier J. Brentjens, MD PhD, Parastoo B. Dahi, MD, Claudia Diamonte, RN, Jessica Flynn, BS, Sergio A Giralt, MD, Elizabeth Halton, NP-BC AOCNP, Maria Lia Palomba, MD, Miriam Sanchez-Escamilla, MD, Craig S. Sauter, MD, Michael Scordo, MD, Gunjan L. Shah, MD, Jae H. Park, MD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4458.
DOI: https://doi.org/10.1182/blood-2019-126022
Published: 2019
Journal Articles

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

Carlos R. Bachier, MD, Maria Lia Palomba, MD, Jeremy S. Abramson, MD MMSc, Charalambos Andreadis, MD MSCE, Alison R. Sehgal, MD, John Godwin, Gerhard C. Hildebrandt, MD, Tanya Siddiqi, MD, Don Stevens, MD, Thalia Farazi, Ana Kostic, Nikolaus S. Trede, Lei Wang, PhD, James Lymp, PhD, Tennille Thelen, Ken Ogasawara, David G. Maloney, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2868.
DOI: https://doi.org/10.1182/blood-2019-127566
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, Ranjana H Advani, MD, Lihua E Budde, MD PhD, Paul M. Barr, MD, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Louis S. Constine, MD, Savita Dandapani, MD PhD, Esther Drill, PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, Clare Grieve, BA, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T Hoppe, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Heiko Schoder, MD, David J. Straus, MD, Shreya Vemuri, Joanna C Yang, MD MPH, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2834.
DOI: https://doi.org/10.1182/blood-2019-123150
Published: 2019
Journal Articles

A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL "Armored" CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Transformation

Jae H. Park, MD, Maria Lia Palomba, MD, Connie Lee Batlevi, MD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Brigitte Senechal, PhD, Richard R. Furman, MD, Yvette Bernal, MS, Malloury Hall, BA, John Pineda, RN, Claudia Diamonte, RN, Elizabeth Halton, NP-BC AOCNP, Renier J. Brentjens, MD PhD, Michel Sadelain, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 224.
DOI: https://doi.org/10.1182/blood-2018-99-117737
Published: 2018
Journal Articles

Intestinal Microbiota Composition Prior to CAR T Cell Infusion Correlates with Efficacy and Toxicity

Melody Smith, MD, Eric R. Littmann, BA, John B. Slingerland, BSc, Annelie Clurman, BA, Ann E. Slingerland, BSc, Ying Taur, MD MPH, Jonas Schluter, PhD, Jae H. Park, MD, Roisin O'Cearbhaill, MD, Sham Mailankody, MBBS, Eric L. Smith, MD PhD, Maria Lia Palomba, MD, Oladapo Yeku, MD PhD, Jonathan U. Peled, MD, Elizabeth Halton, NP-BC AOCNP, Claudia Diamonte, RN, Jason Chan, Malloury Hall, BA, Pavan Anant, BS, Peter Kane, BA, Sergio Giralt, MD, Isabelle Riviere, PhD, Renier J. Brentjens, MD PhD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3492.
DOI: https://doi.org/10.1182/blood-2018-99-118628
Published: 2018
Journal Articles

Atezolizumab in Combination with Obinutuzumab and Lenalidomide Demonstrates Favorable Activity and Manageable Toxicity in Patients with Relapsed/Refractory Follicular Lymphoma (FL): An Interim Analysis of a Phase Ib/II Trial

Gilles Salles, MD PhD, Nilanjan Ghosh, MD PhD, Izidore S. Lossos, MD, Maria Lia Palomba, MD, Amitkumar Mehta, MD, Olivier Casasnovas, Don Stevens, MD, Ana Abajo, Tina Nielsen, Surya Chitra, Michael Wenger, Franck Morschhauser
Journal: Blood
Blood (2018) 132 (Supplement 1): 1603.
DOI: https://doi.org/10.1182/blood-2018-99-114992
Published: 2018
Journal Articles

Resource Utilization Early after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

Gunjan L. Shah, MDMS, Jae H. Park, MD, Craig S. Sauter, MD, Elaine Duck, RN MS MA, Elizabeth Halton, NP-BC AOCNP, Maria Lia Palomba, MD, Connie Lee Batlevi, MD, Anas Younes, MD, Mark Blaine Geyer, MD, Eric L. Smith, MD PhD, Sham Mailankody, MBBS, Elena Mead, MD, Bianca Santomasso, MD PhD, Miguel-Angel Perales, MD, Paul Sabbatini, MD, Sergio Giralt, MD, Renier J. Brentjens, MD PhD, Peter Bach, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 616.
DOI: https://doi.org/10.1182/blood-2018-99-114093
Published: 2018
Journal Articles

Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial

Sham Mailankody, MBBS, Arnab Ghosh, MBBS, PhD, Mette Staehr, PhD, Terence J Purdon, MS, Mikhail Roshal, MD PhD, Elizabeth Halton, NP-BC AOCNP, Claudia Diamonte, RN, John Pineda, RN, Pavan Anant, BS, Yvette Bernal, MS, Analisa Wills, Neha Korde, MD, Nikoletta Lendvai, MDPhD, Alexander M. Lesokhin, MD, Hani Hassoun, MD, Malin Hultcrantz, MD PhD, Heather J. Landau, MD, Gunjan L. Shah, MD, Michael Scordo, MD, David J. Chung, MDPhD, Oscar B Lahoud, MD, Pallavi Khattar, MD, Carlos Fernandez de Larrea, MD PhD, Qi Gao, Achim Jungbluth, MDPhD, Jae H. Park, MD, Kevin J. Curran, MD, Craig S. Sauter, MD, Maria Lia Palomba, MD, Brigitte Senechal, PhD, Xiuyan Wang, PhD, Ahmet Dogan, MD PhD, Sergio Giralt, MD, Isabelle Riviere, PhD, Ola Landgren, MD PhD, Renier J. Brentjens, MD PhD, Eric L. Smith, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 959.
DOI: https://doi.org/10.1182/blood-2018-99-119717
Published: 2018
Journal Articles

Ibrutinib for the Treatment of Bing-Neel Syndrome

Gilad Itchaki, Jonas Paludo, MD, Maria Lia Palomba, MD, Marzia Varettoni, MD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Julio C. Chavez, MD, Christian Buske, MD, Alessandra Tedeschi, MD, David Simpson, MBChB, FRACP, FRCPA, Constantine S. Tam, MBBS (Hons), MD FRACP, FRCPA, Samar Issa, FRACP, Stephen M. Ansell, MD PhD, Steven P Treon, MD PhD FRCP, Jorge J. Castillo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1609.
DOI: https://doi.org/10.1182/blood-2018-99-116788
Published: 2018